These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 32556865)

  • 1. Machine learning-based development and validation of a scoring system for progression-free survival in liver cancer.
    Liu X; Hou Y; Wang X; Yu L; Wang X; Jiang L; Yang Z
    Hepatol Int; 2020 Jul; 14(4):567-576. PubMed ID: 32556865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Prognostic Score Based on Artificial Intelligence in Hepatocellular Carcinoma: A Long-Term Follow-Up Analysis.
    Liu X; Wang X; Yu L; Hou Y; Jiang Y; Wang X; Han J; Yang Z
    Front Oncol; 2022; 12():817853. PubMed ID: 35712507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic model for predicting recurrence in hepatocellular carcinoma patients with high systemic immune-inflammation index based on machine learning in a multicenter study.
    Lu N; Sheng S; Xiong Y; Zhao C; Qiao W; Ding X; Chen J; Zhang Y
    Front Immunol; 2024; 15():1459740. PubMed ID: 39315112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomogram for prediction of long-term survival with hepatocellular carcinoma based on NK cell counts.
    Yu L; Liu X; Wang X; Zhou D; Yan H; Xie Y; Pu Q; Zhang K; Yang Z
    Ann Hepatol; 2022; 27(2):100672. PubMed ID: 35065261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation and ranking of seven staging systems of hepatocellular carcinoma.
    Chen ZH; Hong YF; Lin J; Li X; Wu DH; Wen JY; Chen J; Ruan DY; Lin Q; Dong M; Wei L; Wang TT; Lin ZX; Ma XK; Wu XY; Xu R
    Oncol Lett; 2017 Jul; 14(1):705-714. PubMed ID: 28693224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology.
    Abbas Z; Siddiqui AU; Luck NH; Hassan M; Mirza R; Naqvi A; Rizvi AH
    J Pak Med Assoc; 2008 Nov; 58(11):602-7. PubMed ID: 19024130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of unresectable hepatocellular carcinoma: comparison of seven staging systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese cohort.
    Zhang JF; Shu ZJ; Xie CY; Li Q; Jin XH; Gu W; Jiang FJ; Ling CQ
    PLoS One; 2014; 9(3):e88182. PubMed ID: 24609114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization.
    Zhou DS; Xu L; Luo YL; He FY; Huang JT; Zhang YJ; Chen MS
    World J Gastroenterol; 2015 May; 21(18):5582-90. PubMed ID: 25987783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel risk scoring system predicts overall survival of hepatocellular carcinoma using cox proportional hazards machine learning method.
    Xin H; Li Y; Wang Q; Liu R; Zhang C; Zhang H; Su X; Bai B; Li N; Zhang M
    Comput Biol Med; 2024 Aug; 178():108663. PubMed ID: 38905890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-parametric prognostic model based on clinicopathologic features: vessels encapsulating tumor clusters and hepatic plates predict overall survival in hepatocellular carcinoma patients.
    Xiong SP; Wang CH; Zhang MF; Yang X; Yun JP; Liu LL
    J Transl Med; 2024 May; 22(1):472. PubMed ID: 38762511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial neural networking model for the prediction of post-hepatectomy survival of patients with early hepatocellular carcinoma.
    Qiao G; Li J; Huang A; Yan Z; Lau WY; Shen F
    J Gastroenterol Hepatol; 2014 Dec; 29(12):2014-20. PubMed ID: 24989634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep learning models for predicting the survival of patients with hepatocellular carcinoma based on a surveillance, epidemiology, and end results (SEER) database analysis.
    Wang S; Shao M; Fu Y; Zhao R; Xing Y; Zhang L; Xu Y
    Sci Rep; 2024 Jun; 14(1):13232. PubMed ID: 38853169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis.
    Xu XS; Wan Y; Song SD; Chen W; Miao RC; Zhou YY; Zhang LQ; Qu K; Liu SN; Zhang YL; Dong YF; Liu C
    World J Gastroenterol; 2014 Aug; 20(31):10944-52. PubMed ID: 25152598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
    Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
    World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of Artificial Neural Networks for Survival Prediction Model for Patients with Spontaneous Hepatocellular Carcinoma Rupture After Transcatheter Arterial Embolization.
    Qiu Y; Wang T; Yang X; Shen S; Yang Y; Wang W
    Cancer Manag Res; 2021; 13():7463-7477. PubMed ID: 34611440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients.
    Liang Y; Zhang Z; Zhong D; Lai C; Dai Z; Zou H; Feng T; Shang J; Shi Y; Huang X
    Front Oncol; 2022; 12():913731. PubMed ID: 36016629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging Predictors of Survival in Patients with Single Small Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
    Park C; Kim JH; Kim PH; Kim SY; Gwon DI; Chu HH; Park M; Hur J; Kim JY; Kim DJ
    Korean J Radiol; 2021 Feb; 22(2):213-224. PubMed ID: 32901464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.
    Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Lee PC; Chau GY; Lui WY; Lee SD; Wu JC
    J Gastroenterol Hepatol; 2005 May; 20(5):765-71. PubMed ID: 15853992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma.
    Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Park MS; Kim EH; Seong J; Lee DY; Han KH
    Liver Int; 2012 Aug; 32(7):1120-7. PubMed ID: 22524688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.